Arcadia Biosciences produces innovative wellness products. Recently, the company terminated a proposed business combination with Roosevelt Resources. Arcadia is now focused on growing its Zola® coconut water brand while evaluating strategic alternatives.
For the full year 2025, total revenues were $4,858,000. The net loss (EPS) was $1.71 per share for the year. Fourth-quarter revenues were $901,000 , with an EPS loss of $0.97 per share.
Zola brand revenues increased 17% year-over-year. Furthermore, Arcadia secured approximately $2.1 million in gross proceeds from the exercise of preferred investment options to improve its balance sheet.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.
